INR 208.85
(3.37%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 149.97 Million INR | -27.47% |
2022 | 206.76 Million INR | -30.48% |
2021 | 297.42 Million INR | 0.06% |
2020 | 297.24 Million INR | 1.36% |
2019 | 293.25 Million INR | -10.3% |
2018 | 326.92 Million INR | -36.44% |
2017 | 514.33 Million INR | 8.01% |
2016 | 476.19 Million INR | 19.53% |
2015 | 398.37 Million INR | 20.49% |
2014 | 330.62 Million INR | 8.08% |
2013 | 305.89 Million INR | 1.73% |
2012 | 300.68 Million INR | -14.62% |
2011 | 352.16 Million INR | 56.15% |
2010 | 225.53 Million INR | 0.56% |
2009 | 224.28 Million INR | 1.92% |
2008 | 220.05 Million INR | -34.33% |
2007 | 335.06 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2024 Q2 | 167.98 Million INR | 0.0% |
2023 Q2 | 201.84 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 149.97 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 149.97 Million INR | -27.47% |
2022 FY | 206.76 Million INR | -30.48% |
2022 Q4 | 206.76 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 193.54 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 297.42 Million INR | 0.06% |
2021 Q4 | 297.42 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 290.16 Million INR | 0.0% |
2020 FY | 297.24 Million INR | 1.36% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 154.48 Million INR | 0.0% |
2020 Q4 | 297.24 Million INR | 0.0% |
2019 Q2 | 254.83 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 FY | 293.25 Million INR | -10.3% |
2019 Q4 | 293.25 Million INR | 0.0% |
2018 FY | 326.92 Million INR | -36.44% |
2018 Q4 | 326.92 Million INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 326.65 Million INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 FY | 514.33 Million INR | 8.01% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | 560.61 Million INR | 0.0% |
2017 Q4 | 514.33 Million INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 FY | 476.19 Million INR | 19.53% |
2016 Q4 | 476.19 Million INR | 0.0% |
2016 Q2 | 411.57 Million INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 Q1 | - INR | -100.0% |
2015 Q2 | 396.27 Million INR | 0.0% |
2015 Q4 | 398.37 Million INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2015 FY | 398.37 Million INR | 20.49% |
2014 Q2 | 346 Million INR | 0.0% |
2014 FY | 330.62 Million INR | 8.08% |
2014 Q4 | 330.62 Million INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2013 FY | 305.89 Million INR | 1.73% |
2013 Q1 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2013 Q2 | 291.89 Million INR | 0.0% |
2013 Q4 | 305.89 Million INR | 0.0% |
2012 FY | 300.68 Million INR | -14.62% |
2012 Q4 | 300.68 Million INR | 0.0% |
2012 Q2 | 367.46 Million INR | 0.0% |
2011 Q4 | 352.16 Million INR | 0.0% |
2011 Q2 | - INR | 0.0% |
2011 FY | 352.16 Million INR | 56.15% |
2010 FY | 225.53 Million INR | 0.56% |
2009 FY | 224.28 Million INR | 1.92% |
2008 FY | 220.05 Million INR | -34.33% |
2007 FY | 335.06 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.088% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.847% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 97.75% |
Granules India Limited | 13 Billion INR | 98.847% |
Indoco Remedies Limited | 3.53 Billion INR | 95.752% |
Achyut Healthcare Limited | 568 Thousand INR | -26303.169% |
Ajanta Pharma Limited | 8.28 Billion INR | 98.19% |
Alkem Laboratories Limited | 26.61 Billion INR | 99.436% |
Alpa Laboratories Limited | 136.65 Million INR | -9.745% |
Brooks Laboratories Limited | 96.1 Million INR | -56.043% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 93.419% |
Bajaj HealthCare Limited | 1.44 Billion INR | 89.588% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 87.339% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.764% |
Eris Lifesciences Limited | 1.89 Billion INR | 92.066% |
FDC Limited | 3.88 Billion INR | 96.144% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.403% |
Gufic Biosciences Limited | 2 Billion INR | 92.52% |
Ind-Swift Laboratories Limited | 104.57 Million INR | -43.406% |
Ipca Laboratories Limited | 24.71 Billion INR | 99.393% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | -53.087% |
Lasa Supergenerics Limited | 190.43 Million INR | 21.248% |
Laurus Labs Limited | 18.45 Billion INR | 99.187% |
Lupin Limited | 49.53 Billion INR | 99.697% |
Mankind Pharma Limited | 15.53 Billion INR | 99.035% |
Medicamen Biotech Limited | 593.75 Million INR | 74.742% |
Medico Remedies Limited | 163.37 Million INR | 8.203% |
Megasoft Limited | - INR | -Infinity% |
NATCO Pharma Limited | 7 Billion INR | 97.859% |
Piramal Pharma Limited | 21.75 Billion INR | 99.311% |
RPG Life Sciences Limited | 1.01 Billion INR | 85.151% |
Sigachi Industries Limited | 707.2 Million INR | 78.794% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.848% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 93.513% |
Syncom Formulations (India) Limited | 210.81 Million INR | 28.862% |
Unichem Laboratories Limited | 7.04 Billion INR | 97.872% |
Wanbury Limited | 360.23 Million INR | 58.368% |
Windlas Biotech Limited | 621.89 Million INR | 75.885% |
ZIM Laboratories Limited | 812.62 Million INR | 81.545% |
Zydus Lifesciences Limited | 34.41 Billion INR | 99.564% |
Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
Divi's Laboratories Limited | 31.84 Billion INR | 99.529% |
Hester Biosciences Limited | 755.81 Million INR | 80.158% |
Procter & Gamble Health Limited | 1.09 Billion INR | 86.255% |
Amrutanjan Health Care Limited | 289.04 Million INR | 48.116% |
Bal Pharma Limited | 878.11 Million INR | 82.921% |
Strides Pharma Science Limited | 11.26 Billion INR | 98.668% |
Venus Remedies Limited | 1.21 Billion INR | 87.676% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 97.667% |
Nectar Lifesciences Limited | 7.09 Billion INR | 97.885% |
Shilpa Medicare Limited | 3.44 Billion INR | 95.652% |
Aarti Drugs Limited | 4.85 Billion INR | 96.913% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 96.47% |
Suven Life Sciences Limited | 7.08 Million INR | -2016.725% |
Ind-Swift Limited | 640.91 Million INR | 76.601% |
Valiant Laboratories Limited | 100.15 Million INR | -49.739% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 97.016% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 95.831% |
Themis Medicare Limited | 705.74 Million INR | 78.75% |
Hikal Limited | 3.03 Billion INR | 95.062% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.342% |
Sequent Scientific Limited | 3.46 Billion INR | 95.669% |
Novartis India Limited | 448.6 Million INR | 66.569% |
Wockhardt Limited | 6.4 Billion INR | 97.657% |
Jubilant Pharmova Limited | 12.89 Billion INR | 98.837% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -488.187% |
Neuland Laboratories Limited | 3.5 Billion INR | 95.72% |
Morepen Laboratories Limited | 2.48 Billion INR | 93.967% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -276.053% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 87.87% |